BioMagnetic Solutions Details
BioMagnetic Solutions is the developer of advanced ferrofluid-based immunomagnetic cell selection platforms with the flexibility to support highly specific, efficient, and scalable cell selection. The innovative FerroSelectâ„¢ Array platform delivers high performance selectivity without the need for columns or expensive consumable sets. Complementary affinity reagents and kits can be integrated into single-use magnetic separation platforms for research, clinical development, and commercial scale use.
Employees:
20 - 49
HQ:
814-689-1801
Location:
State College, PA, US
Revenue:
2.5 - 5 Million
Immunomagnetic Separation IMS
Magnetic Cell Separation
Biomagnetic
Nano magnetic
Ferrofluids
cell therapy immuno oncology
Circulating Tumor Cells CTCs
Antibodies
Nanoparticle Synthesis
Cell Isolation
Immunology
Hematology
Stem Cells
immunotherapy CAR-T
Immunomagnetic IMS
T cell activation expansion
immuno oncology
CTC CTCs
cGMP
gene therapy CD34
clinical-scale
cell therapy
cell selection
stem cells
magnetic beads
dynabeads
Miltenyi
CAR-T
CD34
TCR
circulating tumor cells
MACS
magnetic cell separation
X-GRAFFE
Bioprocessing
T cell expansion
cell therapy reagents
Quality Systems
ancilliary reagents
cGMP ancilliary reagents
HSCT
process development
gene therapy
CliniMACS
Prodigy
cell and gene therapy
cell selection for cell manufacturing
Dynabeads
Cell Selection
Better
Faster
more Flexible Cell Selection for CGT product manufacture
X-GRAFFE clinical-scale Cell Selection System
cGMP clinical-grade cell selection reagents
clinical-grade cGMP ferrofluids
BioTech/Drugs
Commercial Physical Research
Biotechnology